Tandem Diabetes Care Inc
NASDAQ:TNDM
Tandem Diabetes Care Inc
Cash from Investing Activities
Tandem Diabetes Care Inc
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Tandem Diabetes Care Inc
NASDAQ:TNDM
|
Cash from Investing Activities
-$85.7m
|
CAGR 3-Years
34%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-23%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash from Investing Activities
-$658m
|
CAGR 3-Years
22%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
4%
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash from Investing Activities
-$2.6B
|
CAGR 3-Years
-84%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-18%
|
|
Stryker Corp
NYSE:SYK
|
Cash from Investing Activities
-$962m
|
CAGR 3-Years
41%
|
CAGR 5-Years
20%
|
CAGR 10-Years
8%
|
|
Abbott Laboratories
NYSE:ABT
|
Cash from Investing Activities
-$3.1B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-3%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash from Investing Activities
-$1.1B
|
CAGR 3-Years
9%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
See Also
What is Tandem Diabetes Care Inc's Cash from Investing Activities?
Cash from Investing Activities
-85.7m
USD
Based on the financial report for Dec 31, 2023, Tandem Diabetes Care Inc's Cash from Investing Activities amounts to -85.7m USD.
What is Tandem Diabetes Care Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
-23%
The average annual Cash from Investing Activities growth rates for Tandem Diabetes Care Inc have been 34% over the past three years , 1% over the past five years , and -23% over the past ten years .